These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6236932)

  • 21. Systemic therapy of salivary gland hypofunction.
    Fox PC
    J Dent Res; 1987 Feb; 66 Spec No():689-92. PubMed ID: 3476633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs.
    Bagheri H; Schmitt L; Berlan M; Montastruc JL
    Eur J Clin Pharmacol; 1997; 52(5):339-42. PubMed ID: 9272401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between anticholinergic activity and xerostomia and/ or xerophthalmia in the elderly: systematic review.
    Prado-Mel E; Ciudad-Gutiérrez P; Rodríguez-Ramallo H; Sánchez-Fidalgo S; Santos-Ramos B; Villalba-Moreno AM
    BMC Pharmacol Toxicol; 2022 Dec; 23(1):94. PubMed ID: 36539885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction.
    Ferguson MM
    Oral Surg Oral Med Oral Pathol; 1993 Feb; 75(2):186-91. PubMed ID: 8093976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nonsteroidal anti-inflammatory agents: their topical use in the treatment of xerophthalmia secondary to Sjögren's syndrome].
    Giorgi D; Giorgi A; D'Angelo G; Verrastro G; Lai S; Grandinetti F; Gabrieli CB
    Recenti Prog Med; 1997 Sep; 88(9):397-400. PubMed ID: 9380944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Xerostomia and Xerophthalmia in haemodialysis patients].
    Postorino M; Martorano C; Cutrupi S; Marino C; Cozzupoli P; Scudo P; Zoccali C
    G Ital Nefrol; 2002; 19(6):634-40. PubMed ID: 12508168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Xerostomia and asalia due to psychopharmacologic therapy and their treatment with TPMP (trithioparamethoxyphenylpropen)].
    Bruck J; Ogris E; Tschabitscher HT
    Wien Med Wochenschr; 1974 Aug; 124(33-35):495-500. PubMed ID: 4214232
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rihl M; Ulbricht K; Schmidt RE; Witte T
    Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study with physiologic serum, eledoisin and bromhexine in the treatment of dry eye syndromes].
    Vergés Roger C; Pita Salorio D; Rodríguez Alvarez L
    Med Clin (Barc); 1985 Sep; 85(9):347-9. PubMed ID: 4079572
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trial of bromhexine in Sjögren's syndrome.
    Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D
    Ann Ophthalmol; 1981 Aug; 13(8):971-3. PubMed ID: 7027873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dryness of the mouth, a well-known side-effect of psychotropic treatment, and its therapy].
    Lelord G; Etienne T; Jusseaume P; Stephant JL; Andre E
    Ann Med Psychol (Paris); 1973 Jan; 1(1):153-9. PubMed ID: 4723205
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the whole-body distribution of 14C-trithioparamethoxyphenylpropene in mice.
    Isacsson G; Singer P
    Scand J Dent Res; 1985 Jun; 93(3):249-52. PubMed ID: 3860910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a new oral lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial.
    Mouly SJ; Orler JB; Tillet Y; Coudert AC; Oberli F; Preshaw P; Bergmann JF
    J Clin Psychopharmacol; 2007 Oct; 27(5):437-43. PubMed ID: 17873673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPLC determination of anethole trithione and its application to pharmacokinetics in rabbits.
    Jing Q; Shen Y; Ren F; Chen J; Jiang Z; Peng B; Leng Y; Dong J
    J Pharm Biomed Anal; 2006 Nov; 42(5):613-7. PubMed ID: 16824723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxypropylmethylcellulose in the treatment of the dry eye.
    Molemans M; Maudgal PC; Missotten L
    Bull Soc Belge Ophtalmol; 1982; 201():93-7. PubMed ID: 7187263
    [No Abstract]   [Full Text] [Related]  

  • 37. Stomatological approach to Sjögren's syndrome: diagnosis, management and therapeutical timing.
    Minozzi F; Galli M; Gallottini L; Minozzi M; Unfer V
    Eur Rev Med Pharmacol Sci; 2009; 13(3):201-16. PubMed ID: 19673172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of formula ophiopogoins in the treatment of xerostomia and pharyngoxerosis.
    Sugano S; Takeyama I; Ogino S; Kenmochi M; Kaneko T
    Acta Otolaryngol Suppl; 1996; 522():124-9. PubMed ID: 8740826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sjogren's syndrome and the "dry syndrome" in combination with lung diseases].
    Ozerova LV; Dobychina AI
    Probl Tuberk; 1994; (1):28-30. PubMed ID: 8170907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome.
    Takagi Y; Kimura Y; Nakamura T
    Ann Rheum Dis; 2004 Jun; 63(6):749. PubMed ID: 15140789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.